Jullien D - Search Results

1

A screen for deubiquitinating enzymes involved in the G₂/M checkpoint identifies USP50 as a regulator of HSP90-dependent Wee1 stability.

Aressy B, Jullien D, Cazales M, Marcellin M, Bugler B, Burlet-Schiltz O, Ducommun B. Aressy B, et al. Among authors: jullien d. Cell Cycle. 2010 Sep 15;9(18):3815-22. doi: 10.4161/cc.9.18.13133. Epub 2010 Sep 25. Cell Cycle. 2010. PMID: 20930503

2

A new mitotic-cell specific monoclonal antibody.

Cazales M, Quaranta M, Lobjois V, Jullien D, Al Saati T, Delsol G, Ducommun B. Cazales M, et al. Among authors: jullien d. Cell Cycle. 2008 Jan 15;7(2):267-8. doi: 10.4161/cc.7.2.5306. Epub 2007 Nov 7. Cell Cycle. 2008. PMID: 18256524 No abstract available.

3

IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells.

Brezak MC, Valette A, Quaranta M, Contour-Galcera MO, Jullien D, Lavergne O, Frongia C, Bigg D, Kasprzyk PG, Prevost GP, Ducommun B. Brezak MC, et al. Among authors: jullien d. Int J Cancer. 2009 Mar 15;124(6):1449-56. doi: 10.1002/ijc.24080. Int J Cancer. 2009. PMID: 19065668

4

The polo-like kinase 1 regulates CDC25B-dependent mitosis entry.

Lobjois V, Jullien D, Bouché JP, Ducommun B. Lobjois V, et al. Among authors: jullien d. Biochim Biophys Acta. 2009 Mar;1793(3):462-8. doi: 10.1016/j.bbamcr.2008.12.015. Epub 2009 Jan 2. Biochim Biophys Acta. 2009. PMID: 19185590 Free article.

5

Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.

Kolb S, Mondésert O, Goddard ML, Jullien D, Villoutreix BO, Ducommun B, Garbay C, Braud E. Kolb S, et al. Among authors: jullien d. ChemMedChem. 2009 Apr;4(4):633-48. doi: 10.1002/cmdc.200800415. ChemMedChem. 2009. PMID: 19212959

6

Identification of N-terminally truncated stable nuclear isoforms of CDC25B that are specifically involved in G2/M checkpoint recovery.

Jullien D, Bugler B, Dozier C, Cazales M, Ducommun B. Jullien D, et al. Cancer Res. 2011 Mar 1;71(5):1968-77. doi: 10.1158/0008-5472.CAN-10-2453. Cancer Res. 2011. PMID: 21363925

7

Evaluation of checkpoint kinase targeting therapy in acute myeloid leukemia with complex karyotype.

Didier C, Demur C, Grimal F, Jullien D, Manenti S, Ducommun B. Didier C, et al. Among authors: jullien d. Cancer Biol Ther. 2012 Mar;13(5):307-13. doi: 10.4161/cbt.19074. Epub 2012 Mar 1. Cancer Biol Ther. 2012. PMID: 22258035 Free PMC article.

8

Chromatibody, a novel non-invasive molecular tool to explore and manipulate chromatin in living cells.

Jullien D, Vignard J, Fedor Y, Béry N, Olichon A, Crozatier M, Erard M, Cassard H, Ducommun B, Salles B, Mirey G. Jullien D, et al. J Cell Sci. 2016 Jul 1;129(13):2673-83. doi: 10.1242/jcs.183103. Epub 2016 May 20. J Cell Sci. 2016. PMID: 27206857 Free PMC article.

9

cDNA sequence and expression pattern of the Drosophila melanogaster PAPS synthetase gene: a new salivary gland marker.

Jullien D, Crozatier M, Käs E. Jullien D, et al. Mech Dev. 1997 Nov;68(1-2):179-86. doi: 10.1016/s0925-4773(97)00136-6. Mech Dev. 1997. PMID: 9431815 Free article.

10

Three distinct sub-nuclear populations of HMG-I protein of different properties revealed by co-localization image analysis.

Amirand C, Viari A, Ballini JP, Rezaei H, Beaujean N, Jullien D, Käs E, Debey P. Amirand C, et al. Among authors: jullien d. J Cell Sci. 1998 Dec;111 ( Pt 23):3551-61. doi: 10.1242/jcs.111.23.3551. J Cell Sci. 1998. PMID: 9811569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters